Rafferty Asset Management
GHDX

Rafferty Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Rafferty Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-71,084
Closed -$4.82M – 922
2019
Q3 		$4.82M Sell
71,084
-25,592
-26% -$1.76M 0.08% 154
2019
Q2 		$5.62M Buy
96,676
+40,643
+73% +$2.41M 0.1% 135
2019
Q1 		$3.92M Buy
+56,033
New +$4.15M 0.06% 174

Rafferty Asset Management's GHDX Position: Q4 2019 in Review

Rafferty Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 71,084 shares — an estimated $4.82M sold.

Rafferty Asset Management first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $5.62M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Rafferty Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 71,084 Genomic Health, Inc. shares in Q4 2019, an estimated $4.82M.
  • Rafferty Asset Management first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
  • Rafferty Asset Management's Genomic Health, Inc. position peaked at $5.62M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.